SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nutraplus India Ltd (524764)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524764 NSE: Pharmaceuticals & Drugs | Small Cap | Nutraplus India Share Price

₹2.10 0.00 (0.00%)

As on 13-Dec'21 18:01

Nutraplus India Ltd (524764)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524764 NSE: Pharmaceuticals & Drugs | Small Cap | Nutraplus India Share Price

₹2.10 0.00 (0.00%)

As on 13-Dec'21 18:01

Key Metrics
Valuation Multiples
Market Cap
₹7 Cr.
Current Price
₹2.1
52-Week Low / High
₹2 / 2
TTM EPS
₹-14
TTM Sales
₹107 Cr.
Book Value per Share
₹6.3
P/E Ratio
0.00
Industry PE
46.7
Price to Book (P/B)
0.33
Price to Sales (P/S)
0.07
EV/EBITDA
-2.30
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
0.00%
Return on Assets (ROA)
-0.96%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
40.07%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹5 Cr.
Equity
₹17.1 Cr.
Face Value
₹5
All Time Low / High
₹0.27 / 224.73

Nutraplus India stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.8%-2.9%4.1%7.2%-33.4%-37.2%0%0%0%0%-
Value Creation
Index
-0.2-1.2-0.7-0.5-3.4NANANANANA-

Growth Parameters

Sales 77.69110914010700.1000107
Sales YoY Gr.-17.3%19.9%27.9%-23.6%-100%400%-100%NANA-
Adj EPS 2.6-2.100.4-13.2-1.9-0.9-0.1-0-0-14
YoY Gr.--183.1%NA1200%-3482.1%NANANANANA-
BVPS (₹) 20.919.719.720.46.3-0.6-1.5-1.5-1.6-1.66.3
Adj Net
Profit
7.1-7.20.11.3-45-6.4-3-0.2-0.1-0.1-48
Cash Flow from Ops. -9.619.76.712.49.1-14.3-0.20-00-
Debt/CF from Ops. -7.53.4116.18.4-0.1-10.1105.7-225.41000.3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%-100%NA
Adj EPS -154%NANANA
BVPS-175%-175.6%NANA
Share Price -31.3% -4% - -

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
12.9-11.10.12-98.8-65.58531.20.9-588.3
Op. Profit
Mgn %
15.7-2.18.59.2-29.8-1820.2-3724.4000NAN
Net Profit
Mgn %
9.2-80.11-42.2-32641.1-3091.9000-44.9
Debt to
Equity
1.211.11.13.5-0.9-0.3-0.3-0.3-0.3-
Working Cap
Days
3142952431501172,41,11626,6080000
Cash Conv.
Cycle
325645414144,1978,2640000

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales77.5991.04109.14139.56106.670.020.10000
Operating Expenses + 65.4592.9399.91126.90142.500.383.750.130.060.05
Manufacturing Costs8.1313.7412.3711.208.7500.03000
Material Costs52.3072.2681.55108.64116.5503.52000
Employee Cost 2.943.463.684.077.340.070.010.020.020.02
Other Costs 2.083.472.3139.870.310.180.100.040.03
Operating Profit 12.14-1.889.2312.65-35.84-0.36-3.65-0.13-0.06-0.05
Operating Profit Margin (%) 15.6%-2.1%8.5%9.1%-33.6%-1,832.0%-3,724.4%---
Other Income + 0.310.270.193.880.140.090.62000
Exceptional Items 1.1700-2.290-17.800000
Interest 4.865.014.676.857.430.8000.0300
Depreciation 1.722.213.884.034.7000000
Profit Before Tax 7.04-8.840.883.36-47.83-18.87-3.03-0.16-0.06-0.05
Tax -0.89-1.700.741.17000000
Profit After Tax 7.93-7.130.142.19-47.83-18.87-3.03-0.16-0.06-0.05
PAT Margin (%) 10.2%-7.8%0.1%1.6%-44.8%-96,168.3%-3,091.9%---
Adjusted EPS (₹)2.9-2.10.00.6-14.0-5.5-0.9-0.1-0.0-0.0
Dividend Payout Ratio (%)8%0%0%0%0%0%0%0%0%0%

Valuation of Nutraplus India - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 58.2167.2167.2469.4421.61-2.05-5.08-5.24-5.30-5.35
Share Capital 12.6717.0517.0517.0517.0517.0517.0517.0517.0517.05
Reserves 45.5450.1750.1952.404.57-19.10-22.13-22.28-22.35-22.40
Debt +65.8958.4367.0966.8775.881.751.751.761.781.79
Long Term Debt38.9432.0941.6736.330.201.751.751.761.781.79
Short Term Debt26.9626.3325.4330.5375.6700000
Minority Interest0000000000
Trade Payables27.1635.1229.8922.6911.259.778.578.578.588.54
Others Liabilities 14.338.467.3110.702.920.010.160.160.190.19
Total Liabilities 165.60169.22171.53169.70111.659.485.405.255.255.16

Fixed Assets

Net Fixed Assets +32.8938.6472.3182.4481.1900000
Gross Block37.0940.8578.2792.3495.6600000
Accumulated Depreciation4.202.215.969.9014.4700000
CWIP 37.5348.2721.5917.2612.670.120000
Investments 4.154.164.154.150.150.150.150.150.150.15
Inventories25.9322.4124.9437.083.553.550000
Trade Receivables25.4426.1425.0316.432.771.080.520.440.430.34
Cash Equivalents 2.892.062.052.020.830.100.070.050.070.07
Others Assets 36.7627.5421.4610.3310.494.474.664.614.614.61
Total Assets 165.60169.22171.53169.70111.659.485.405.255.255.16

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -9.6119.666.6912.369.07-14.25-0.170.02-0.010
PBT 7.06-8.820.885.65-47.83-18.87-3.03-0.16-0.06-0.05
Adjustment 5.087.238.4310.7645.220.4200.0300
Changes in Working Capital -20.8920.42-1.84-1.0311.724.192.880.110.050.05
Tax Paid -0.83-0.04-0.78-0.74-0.050-0.020.0300
Cash Flow From Investing Activity + -34.42-18.59-10.70-9.74-2.6993.770.12000
Capex -35.76-18.70-10.82-9.86000000
Net Investments 0000-2.8393.740000
Others 1.340.110.130.120.140.030.12000
Cash Flow From Financing Activity + 35.54-1.914-2.66-7.57-80.250.02-0.030.020
Net Proceeds from Shares 10.4610.5700000000
Net Proceeds from Borrowing 23.43-6.849.57-5.33000000
Interest Paid -4.86-5.01-4.67-6.85-7.43-0.45-0-0.03-0-0
Dividend Paid 0000000000
Others 6.51-0.62-0.919.53-0.14-79.800.0200.020
Net Cash Flow -8.48-0.84-0.01-0.03-1.18-0.73-0.03-0.010.010

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)16.15-11.380.213.2-105.05N/AN/AN/AN/AN/A
ROCE (%)10.78-2.864.057.17-33.4N/AN/AN/AN/AN/A
Asset Turnover Ratio0.620.610.650.960.900.01000
PAT to CFO Conversion(x)-1.21N/A47.795.64N/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days82.2092.6084.204627.8002,994.50000
Inventory Days91.7086.7077.9068.8058.9000000
Payable Days178.90157.30145.5088.3053.200949.80000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nutraplus India Ltd FAQs

The current trading price of Nutraplus India on 13-Dec-2021 18:01 is ₹2.10.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Dec-2021 the market cap of Nutraplus India stood at ₹7.16 Cr

The latest P/E ratio of Nutraplus India as of 12-Dec-2021 is 0.00.

The latest P/B ratio of Nutraplus India as of 12-Dec-2021 is 0.33.

The 52-week high of Nutraplus India is ₹2.10 and the 52-week low is ₹1.90.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nutraplus India is ₹107 ( Cr.) .

Data is not available for this company.

The key valuation ratios of Nutraplus India Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

No data found

About Nutraplus India Ltd

Nutraplus Products India (NPIL) was incorporated as a private limited company in February 1990. The company's manufacturing unit was commissioned to make APIs and intermediates in 1995. Various products were made earlier. For a fine organic chemical manufacturing unit, the first 6 to 7 years period was crucial in a sense that proficiency in handling certain unit processes were developed. Based on such expertise, higher value and profitable products then could be taken up. In spite of liberalization of imports, reduction in import duties and indigenous competition, the company has withstood uncertainties.

The company intends to take up manufacture of an API and its intermediates by way of expansion of fixed assets. Up till now, the company adopted a stringy to carry out job working and also make selected products for a merchant exporter on fixed quantity and rate. The products made by the company hence, were exported by the merchant exporter. 

The registered office of the company is located at 7- A Vakil Villa, H F Society Road End, Jogeshwari E Mumbai, Maharashtra 400060.

Product of the company

  • N Bromo Succinimide 
  • N Methyl Nitro Guanidine
  • Chlorhexidine Gluconate  
  • 7- Chloro Quinaldine  
  • M Bromo Anisole
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×